These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 12800807)
21. Efficient strategy for obtaining reliable pharmacokinetic parameters in population compartmental approaches. Lee J; Kang D; Kim E; Kim BH Int J Clin Pharmacol Ther; 2016 Jan; 54(1):11-8. PubMed ID: 26521928 [TBL] [Abstract][Full Text] [Related]
22. Estimating inestimable standard errors in population pharmacokinetic studies: the bootstrap with Winsorization. Ette EI; Onyiah LC Eur J Drug Metab Pharmacokinet; 2002; 27(3):213-24. PubMed ID: 12365204 [TBL] [Abstract][Full Text] [Related]
23. [Modeling and simulation activities to design sampling scheme for population pharmacokinetic study on amlodipine]. Zuo XC; Yuan H; Zhang BK; Ng CM; Barrett JS; Yang GP; Huang ZJ; Pei Q; Guo R; Zhou YN; Jing NN; Di W Yao Xue Xue Bao; 2012 Jul; 47(7):941-6. PubMed ID: 22993862 [TBL] [Abstract][Full Text] [Related]
24. Comparison of ED, EID, and API criteria for the robust optimization of sampling times in pharmacokinetics. Tod M; Rocchisani JM J Pharmacokinet Biopharm; 1997 Aug; 25(4):515-37. PubMed ID: 9561492 [TBL] [Abstract][Full Text] [Related]
25. The influence of assay variability on pharmacokinetic parameter estimation. Graves DA; Locke CS; Muir KT; Miller RP J Pharmacokinet Biopharm; 1989 Oct; 17(5):571-92. PubMed ID: 2614686 [TBL] [Abstract][Full Text] [Related]
26. Circadian rhythm of 5-fluorouracil population pharmacokinetics in patients with metastatic colorectal cancer. Bressolle F; Joulia JM; Pinguet F; Ychou M; Astre C; Duffour J; Gomeni R Cancer Chemother Pharmacol; 1999; 44(4):295-302. PubMed ID: 10447576 [TBL] [Abstract][Full Text] [Related]
27. Impact of dose selection on parameter estimation using a rapid binding approximation model of target-mediated drug disposition. Marathe A; Van Wart S; Mager DE J Pharmacokinet Pharmacodyn; 2011 Apr; 38(2):223-35. PubMed ID: 21165681 [TBL] [Abstract][Full Text] [Related]
28. Estimation of pharmacokinetic parameters by orthogonal regression: comparison of four algorithms. Tod M; Aouimer A; Petitjean O Comput Methods Programs Biomed; 2002 Jan; 67(1):13-26. PubMed ID: 11750944 [TBL] [Abstract][Full Text] [Related]
29. [Effects of multiple-trough sampling design and algorithm on the estimation of population and individual pharmacokinetic parameters]. Ling J; Qian LX; Ding JJ; Jiao Z Yao Xue Xue Bao; 2014 May; 49(5):686-94. PubMed ID: 25151742 [TBL] [Abstract][Full Text] [Related]
30. Desipramine, substrate for CYP2D6 activity: population pharmacokinetic model and design elements of drug-drug interaction trials. Gueorguieva I; Jackson K; Wrighton SA; Sinha VP; Chien JY Br J Clin Pharmacol; 2010 Oct; 70(4):523-36. PubMed ID: 20840444 [TBL] [Abstract][Full Text] [Related]
31. Population pharmacokinetics of tacrolimus in whole blood and plasma in asian liver transplant patients. Sam WJ; Tham LS; Holmes MJ; Aw M; Quak SH; Lee KH; Lim SG; Prabhakaran K; Chan SY; Ho PC Clin Pharmacokinet; 2006; 45(1):59-75. PubMed ID: 16430311 [TBL] [Abstract][Full Text] [Related]
32. Patient characteristics influencing ciclosporin pharmacokinetics and accurate Bayesian estimation of ciclosporin exposure in heart, lung and kidney transplant patients. Saint-Marcoux F; Marquet P; Jacqz-Aigrain E; Bernard N; Thiry P; Le Meur Y; Rousseau A Clin Pharmacokinet; 2006; 45(9):905-22. PubMed ID: 16928152 [TBL] [Abstract][Full Text] [Related]
33. Easy and reliable maximum a posteriori Bayesian estimation of pharmacokinetic parameters with the open-source R package mapbayr. Le Louedec F; Puisset F; Thomas F; Chatelut É; White-Koning M CPT Pharmacometrics Syst Pharmacol; 2021 Oct; 10(10):1208-1220. PubMed ID: 34342170 [TBL] [Abstract][Full Text] [Related]
34. A Bayesian approach for the estimation of patient compliance based on the last sampling information. Barrière O; Li J; Nekka F J Pharmacokinet Pharmacodyn; 2011 Jun; 38(3):333-51. PubMed ID: 21445612 [TBL] [Abstract][Full Text] [Related]
35. Assessing convergence of Markov chain Monte Carlo simulations in hierarchical Bayesian models for population pharmacokinetics. Dodds MG; Vicini P Ann Biomed Eng; 2004 Sep; 32(9):1300-13. PubMed ID: 15493516 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of Bayesian estimation of pharmacokinetic parameters. Tsuchiwata S; Mihara K; Yafune A; Ogata H Ther Drug Monit; 2005 Feb; 27(1):18-24. PubMed ID: 15665741 [TBL] [Abstract][Full Text] [Related]
37. Diazepam pharamacokinetics from preclinical to phase I using a Bayesian population physiologically based pharmacokinetic model with informative prior distributions in WinBUGS. Gueorguieva I; Aarons L; Rowland M J Pharmacokinet Pharmacodyn; 2006 Oct; 33(5):571-94. PubMed ID: 16810558 [TBL] [Abstract][Full Text] [Related]
39. A limited sampling strategy for estimating individual pharmacokinetic parameters of coagulation factor VIII in patients with hemophilia A. Bolon-Larger M; Chamouard V; Bressolle F; Boulieu R Ther Drug Monit; 2007 Feb; 29(1):20-6. PubMed ID: 17304146 [TBL] [Abstract][Full Text] [Related]
40. Sirolimus population pharmacokinetic/pharmacogenetic analysis and bayesian modelling in kidney transplant recipients. Djebli N; Rousseau A; Hoizey G; Rerolle JP; Toupance O; Le Meur Y; Marquet P Clin Pharmacokinet; 2006; 45(11):1135-48. PubMed ID: 17048977 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]